{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:10:40Z","timestamp":1792487440592,"version":"4.5.0"},"reference-count":212,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jconrel.2021.10.020","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T09:06:12Z","timestamp":1635152772000},"page":"342-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: A review"],"prefix":"10.1016","volume":"340","author":[{"given":"Wei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.10.020_bb0005","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bbi.2018.02.004","article-title":"Changes in motor function, cognition, and emotion-related behavior after right hemispheric intracerebral hemorrhage in various brain regions of mouse","volume":"69","author":"Zhu","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.jconrel.2021.10.020_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097423","article-title":"Mouse models of intracerebral hemorrhage in ventricle, cortex, and hippocampus by injections of autologous blood or collagenase","volume":"9","author":"Zhu","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jconrel.2021.10.020_bb0015","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.rcl.2019.07.007","article-title":"Causes of acute stroke: a patterned approach","volume":"57","author":"Knight-Greenfield","year":"2019","journal-title":"Radiol. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0020","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.emc.2016.06.007","article-title":"Transient ischemic attacks: advances in diagnosis and management in the emergency department","volume":"34","author":"Duca","year":"2016","journal-title":"Emerg. Med. Clin. North Am."},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2021.10.020_bb0025","first-page":"S140","article-title":"Acute ischemic stroke: management approach","volume":"23","author":"Chugh","year":"2019","journal-title":"Indian J. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.jconrel.2021.10.020_bb0030","article-title":"Systemic sclerosis is not associated with worse outcomes of patients admitted for ischemic stroke: analysis of the national inpatient sample","volume":"12","author":"Edigin","year":"2020","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jconrel.2021.10.020_bb0035","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1093\/neuros\/nyz359","article-title":"Mechanical thrombectomy in acute ischemic stroke patients performed within and outside clinical trials in the United States","volume":"86","author":"Qureshi","year":"2020","journal-title":"Neurosurgery"},{"issue":"11","key":"10.1016\/j.jconrel.2021.10.020_bb0040","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1161\/STROKEAHA.112.658781","article-title":"National trends in utilization and outcomes of endovascular treatment of acute ischemic stroke patients in the mechanical thrombectomy era","volume":"43","author":"Hassan","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0045","first-page":"100285","article-title":"Factors affecting time between symptom onset and emergency department arrival in stroke patients","volume":"21","author":"Le","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s42466-019-0010-8","article-title":"Distribution and evolution of acute interventional ischemic stroke treatment in Germany from 2010 to 2016","volume":"1","author":"Weber","year":"2019","journal-title":"Neurol. Res. Pract."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0055","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.3389\/fimmu.2019.02505","article-title":"Platelets as modulators f cerebral ischemia\/reperfusion injury","volume":"10","author":"Stegner","year":"2019","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.jconrel.2021.10.020_bb0060","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s10072-019-03936-x","article-title":"Posterior circulation ischemic stroke-a review part II: imaging and acute treatment","volume":"40","author":"Sparaco","year":"2019","journal-title":"Neurol. Sci."},{"issue":"10","key":"10.1016\/j.jconrel.2021.10.020_bb0065","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/medicina55100687","article-title":"Epidemiology of heart disease of uncertain etiology: a population study and review of the problem","volume":"55","author":"Menotti","year":"2019","journal-title":"Medicina (Kaunas)"},{"issue":"11","key":"10.1016\/j.jconrel.2021.10.020_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028695","article-title":"Direct estimates of disability-adjusted life years lost due to stroke: a cross-sectional observational study in a demographic surveillance site in rural Gadchiroli, India","volume":"9","author":"Sudharsanan","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0075","doi-asserted-by":"crossref","first-page":"110983","DOI":"10.1016\/j.fct.2019.110983","article-title":"The relationship of obesity with lifestyle and dietary exposure to endocrine-disrupting chemicals","volume":"136","author":"Heras-Gonz\u00e1lez","year":"2020","journal-title":"Food Chem. Toxicol."},{"issue":"15","key":"10.1016\/j.jconrel.2021.10.020_bb0080","doi-asserted-by":"crossref","first-page":"e1559","DOI":"10.1212\/WNL.0000000000009234","article-title":"First-ever ischemic stroke and increased risk of incident heart disease in older adults","volume":"94","author":"Sposato","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jconrel.2021.10.020_bb0085","doi-asserted-by":"crossref","first-page":"165260","DOI":"10.1016\/j.bbadis.2018.09.012","article-title":"Current advances in ischemic stroke research and therapies","volume":"2020","author":"Barthels","year":"1866","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0090","doi-asserted-by":"crossref","first-page":"100826","DOI":"10.1016\/j.mam.2019.10.003","article-title":"Neurological disorders and mitochondria","volume":"71","author":"Cabral-Costa","year":"2020","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0095","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jama.283.9.1145","article-title":"Intravenous tissue-type plasminogen activator for treatment of acute stroke: the standard treatment with alteplase to reverse stroke (STARS) study","volume":"283","author":"Albers","year":"2000","journal-title":"J. Am. Med. Assoc."},{"issue":"4","key":"10.1016\/j.jconrel.2021.10.020_bb0100","first-page":"213","article-title":"Ischemia-reperfusion injury in the brain: mechanisms and potential therapeutic strategies","volume":"5","author":"Lin","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.jconrel.2021.10.020_bb0105","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1503\/cmaj.140355","article-title":"Diagnosis and management of acute ischemic stroke: speed is critical","volume":"187","author":"Musuka","year":"2015","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.jconrel.2021.10.020_bb0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7461\/jcen.2021.E2020.11.002","article-title":"Mechanical thrombectomy for acute ischemic stroke with occlusion of the M2 segment of the middle cerebral artery: a literature review","volume":"23","author":"Cho","year":"2021","journal-title":"J Cerebrovasc Endovasc Neurosurg"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0115","doi-asserted-by":"crossref","first-page":"101212","DOI":"10.1016\/j.smrv.2019.101212","article-title":"Wake-up stroke: from pathophysiology to management","volume":"48","author":"Peter-Derex","year":"2019","journal-title":"Sleep Med. Rev."},{"issue":"6","key":"10.1016\/j.jconrel.2021.10.020_bb0120","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.rcl.2019.07.009","article-title":"Imaging of acute stroke: current state","volume":"57","author":"Hetts","year":"2019","journal-title":"Radiol. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0125","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3389\/fnins.2019.01301","article-title":"Energy dynamics in the brain: contributions of astrocytes to metabolism and pH homeostasis","volume":"13","author":"Deitmer","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0130","doi-asserted-by":"crossref","first-page":"101747","DOI":"10.1016\/j.jddst.2020.101747","article-title":"Hyaluronic acid functionalized nanoparticles for simultaneous delivery of curcumin and resveratrol for management of chronic diabetic wounds: fabrication, characterization, stability and in vitro release kinetics","volume":"57","author":"Hussain","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0135","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/03639045.2018.1542704","article-title":"Nanoencapsulation of betamethasone valerate using high pressure homogenization-solvent evaporation technique: optimization of formulation and process parameters for efficient dermal targeting","volume":"45","author":"Md","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0140","doi-asserted-by":"crossref","first-page":"102228","DOI":"10.1016\/j.jddst.2020.102228","article-title":"Efficient design to fabricate smart Lumefantrine nanocrystals using DENA\u00ae particle engineering technology: Characterisation, in vitro and in vivo antimalarial evaluation and assessment of acute and sub-acute toxicity","volume":"61","author":"Shah","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0145","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s13346-018-0508-6","article-title":"Polymeric nanoparticles for topical delivery of alpha and beta arbutin: preparation and characterization","volume":"9","author":"Ayumi","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"issue":"8","key":"10.1016\/j.jconrel.2021.10.020_bb0150","first-page":"1967","article-title":"New developments and clinical transition of hyaluronic acid-based nanotherapeutics for treatment of cancer: reversing multidrug resistance, tumour-specific targetability and improved anticancer efficacy","volume":"46","author":"Safdar","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0155","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jconrel.2019.04.027","article-title":"Nanomedicines for improved targetability to inflamed synovium for treatment of rheumatoid arthritis: multi-functionalization as an emerging strategy to optimize therapeutic efficacy","volume":"303","author":"Fang","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0160","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2018.10.024","article-title":"Nanomedicines guided nanoimaging probes and nanotherapeutics for early detection of lung cancer and abolishing pulmonary metastasis: critical appraisal of newer developments and challenges to clinical transition","volume":"292","author":"Gao","year":"2018","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2021.10.020_bb0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijpharm.2013.01.024","article-title":"Self-assembled polymeric nanoparticles for percutaneous co-delivery of hydrocortisone\/hydroxytyrosol: an ex vivo and in vivo study using an NC\/Nga mouse model","volume":"444","author":"Hussain","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.jconrel.2021.10.020_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113143","article-title":"Efficient immuno-modulation of TH1\/TH2 biomarkers in 2,4-dinitrofluorobenzene-induced atopic dermatitis: nanocarrier-mediated transcutaneous co-delivery of anti-inflammatory and antioxidant drugs","volume":"9","author":"Hussain","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0175","first-page":"5143","article-title":"Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisone-loaded chitosan nanoparticles","volume":"9","author":"Hussain","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0180","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2019.02.031","article-title":"Emerging paradigms in nanotechnology for imaging and treatment of cerebral ischemia","volume":"300","author":"Kaviarasi","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0185","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.bpj.2016.05.051","article-title":"Neuroprotective role of gap junctions in a neuron astrocyte network model","volume":"111","author":"Huguet","year":"2016","journal-title":"Biophys. J."},{"issue":"4","key":"10.1016\/j.jconrel.2021.10.020_bb0190","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1017\/S1092852919001354","article-title":"Pathophysiologic mechanisms, neuroimaging and treatment in wake-up stroke","volume":"25","author":"Elfil","year":"2020","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0195","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/mrm.21181","article-title":"Proton transfer ratio, lactate, and intracellular pH in acute cerebral ischemia","volume":"57","author":"Jokivarsi","year":"2007","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0200","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/ars.2007.1957","article-title":"Redox regulation of cell survival","volume":"10","author":"Trachootham","year":"2008","journal-title":"Antioxid. Redox Signal."},{"issue":"11","key":"10.1016\/j.jconrel.2021.10.020_bb0205","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S1474-4422(19)30078-X","article-title":"Global brain inflammation in stroke","volume":"18","author":"Shi","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fphys.2020.00129","article-title":"The role of clock genes in fibrinolysis regulation: circadian disturbance and its effect on fibrinolytic activity","volume":"11","author":"Carmona","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0215","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1742-2094-8-164","article-title":"Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood- brain barrier damage and brain oedema independently of infarct size","volume":"8","author":"D\u00e9nes","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0220","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1742-2094-7-74","article-title":"The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia","volume":"7","author":"Ceulemans","year":"2010","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.jconrel.2021.10.020_bb0225","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s12264-015-1567-z","article-title":"Experimental animal models and inflammatory cellular changes in cerebral ischemic and hemorrhagic stroke","volume":"31","author":"Yan","year":"2015","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0230","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainresbull.2014.02.005","article-title":"A neuroproteomic and systems biology analysis of rat brain post intracerebral hemorrhagic stroke","volume":"102","author":"Ren","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbi.2018.12.018","article-title":"Magnolol exhibits anti-inflammatory and neuroprotective effects in a rat model of intracerebral haemorrhage","volume":"77","author":"Zhou","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.jconrel.2021.10.020_bb0240","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2174\/1871527313666141023094720","article-title":"Inflammation in ischemic stroke: mechanisms, consequences and possible drug targets","volume":"13","author":"Ahmad","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"4","key":"10.1016\/j.jconrel.2021.10.020_bb0245","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1161\/STROKEAHA.107.498212","article-title":"Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke","volume":"39","author":"Caso","year":"2008","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.jconrel.2021.10.020_bb0250","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/157340310791658758","article-title":"Fibrinolytic therapy in acute stroke","volume":"6","author":"Mill\u00e1n","year":"2010","journal-title":"Curr. Cardiol. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2021.10.020_bb0255","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/1573403X10666140320144637","article-title":"Reperfusion therapies for acute ischemic stroke: an update","volume":"10","author":"Dorado","year":"2014","journal-title":"Curr. Cardiol. Rev."},{"issue":"8","key":"10.1016\/j.jconrel.2021.10.020_bb0260","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1161\/01.STR.0000082721.62796.09","article-title":"Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke","volume":"34","author":"Higashida","year":"2003","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.jconrel.2021.10.020_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147287","article-title":"Endovascular treatment with stent-retriever devices for acute ischemic stroke: a meta-analysis of randomized controlled trials","volume":"11","author":"Bush","year":"2016","journal-title":"PLoS One"},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2021.10.020_bb0270","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000089368","article-title":"Recent advances in the interventional treatment of acute ischemic stroke","volume":"20","author":"Higashida","year":"2005","journal-title":"Cerebrovasc. Dis."},{"issue":"8","key":"10.1016\/j.jconrel.2021.10.020_bb0275","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1586\/ern.11.102","article-title":"Advances in revascularization for acute ischemic stroke treatment: an update","volume":"11","author":"Eesa","year":"2011","journal-title":"Expert. Rev. Neurother."},{"issue":"3","key":"10.1016\/j.jconrel.2021.10.020_bb0280","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/STROKEAHA.118.023954","article-title":"Antiplatelet therapy in ischemic stroke and transient ischemic attack","volume":"50","author":"Hackam","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0285","first-page":"7","article-title":"Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes","volume":"2","author":"Worthley","year":"2011","journal-title":"Patient Relat. Outcome Meas."},{"issue":"7","key":"10.1016\/j.jconrel.2021.10.020_bb0290","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.07.012","article-title":"Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(\u00ae) and VerifyNow(\u00ae)","volume":"22","author":"Kinsella","year":"2013","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"6","key":"10.1016\/j.jconrel.2021.10.020_bb0295","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1185\/030079907X199727","article-title":"Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines","volume":"23","author":"Hankey","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"issue":"4","key":"10.1016\/j.jconrel.2021.10.020_bb0300","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/14017431.2019.1620962","article-title":"Aspirin plus clopidogrel versus aspirin mono-therapy for ischemic stroke: a meta-analysis","volume":"53","author":"Ye","year":"2019","journal-title":"Scand. Cardiovasc. J."},{"issue":"5","key":"10.1016\/j.jconrel.2021.10.020_bb0305","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1161\/STROKEAHA.119.028400","article-title":"Use of dual antiplatelet therapy following ischemic stroke","volume":"51","author":"Dong","year":"2020","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.jconrel.2021.10.020_bb0310","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1212\/01.WNL.0000156357.50448.8A","article-title":"Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks","volume":"64","author":"Hankey","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0315","doi-asserted-by":"crossref","first-page":"k5130","DOI":"10.1136\/bmj.k5130","article-title":"Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline","volume":"363","author":"Prasad","year":"2018","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0320","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/CNQ.0000000000000298","article-title":"Indications and evidence for dual antiplatelet therapy after acute ischemic stroke","volume":"43","author":"Ringler","year":"2020","journal-title":"Crit. Care Nurs. Q."},{"issue":"3","key":"10.1016\/j.jconrel.2021.10.020_bb0325","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/1747493019828548","article-title":"New opportunities to optimize antithrombotic therapy for secondary stroke prevention","volume":"14","author":"Kim","year":"2019","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0330","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jocn.2019.08.001","article-title":"Neuroprotection for ischemic stroke in the endovascular era: a brief report on the future of intra-arterial therapy","volume":"69","author":"Griauzde","year":"2019","journal-title":"ASJ Clin. Neurosci."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0335","doi-asserted-by":"crossref","first-page":"119209","DOI":"10.1016\/j.biomaterials.2019.05.020","article-title":"Encapsulation of tissue plasminogen activator in pH-sensitive self-assembled antioxidant nanoparticles for ischemic stroke treatment - synergistic effect of thrombolysis and antioxidant","volume":"215","author":"Mei","year":"2019","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.jconrel.2021.10.020_bb0340","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/antiox3030472","article-title":"Oxidative stress and the use of antioxidants in stroke","volume":"3","author":"Shirley","year":"2014","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0345","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s12035-016-9695-7","article-title":"Combining normobaric oxygen with ethanol or hypothermia prevents brain damage from thromboembolic stroke via PKC-Akt-NOX modulation","volume":"54","author":"Cai","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.jconrel.2021.10.020_bb0350","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/1440-1681.12775","article-title":"Naringenin prevents ischaemic stroke damage via anti-apoptotic and anti-oxidant effects","volume":"44","author":"Wang","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"6","key":"10.1016\/j.jconrel.2021.10.020_bb0355","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1747-4949.2009.00387.x","article-title":"Oxidative stress and its role in the pathogenesis of ischaemic stroke","volume":"4","author":"Allen","year":"2009","journal-title":"Int. J. Stroke"},{"issue":"1","key":"10.1016\/j.jconrel.2021.10.020_bb0360","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1527-3458.2006.00009.x","article-title":"Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury","volume":"12","author":"Yoshida","year":"2006","journal-title":"CNS Drug Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2021.10.020_bb0365","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.seizure.2008.06.012","article-title":"Neuroprotective effects of edaravone, a free radical scavenger, on the rat hippocampus after pilocarpine-induced status epilepticus","volume":"18","author":"Kamida","year":"2009","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.jconrel.2021.10.020_bb0370","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3892\/etm.2011.281","article-title":"Potential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarction","volume":"2","author":"Kikuchi","year":"2011","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2021.10.020_bb0375","first-page":"899","article-title":"Beyond neurological disease: new targets for edaravone (review)","volume":"28","author":"Kikuchi","year":"2011","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2021.10.020_bb0380","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1248\/yakushi.124.99","article-title":"Research and development of the free radical scavenger edaravone as a neuroprotectant","volume":"124","author":"Watanabe","year":"2004","journal-title":"Yakugaku Zasshi"},{"issue":"5","key":"10.1016\/j.jconrel.2021.10.020_bb0385","doi-asserted-by":"crossref","first-page":"773","DOI":"10.4103\/1673-5374.268898","article-title":"Neuroprotective effects of minocycline on focal cerebral ischemia injury: a systematic review","volume":"15","author":"Naderi","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0390","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12974-015-0264-1","article-title":"MCP-induced protein 1 mediates the minocycline-induced neuroprotection against cerebral ischemia\/reperfusion injury in vitro and in vivo","volume":"12","author":"Jin","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0395","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jocn.2019.04.012","article-title":"Neuroprotective effects of minocycline and progesterone on white matter injury after focal cerebral ischemia","volume":"64","author":"Faheem","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0400","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brainres.2014.03.005","article-title":"Minocycline mitigates motor impairments and cortical neuronal loss induced by focal ischemia in rats chronically exposed to ethanol during adolescence","volume":"1561","author":"Oliveira","year":"2014","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.jconrel.2021.10.020_bb0405","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00415-018-8935-3","article-title":"Minocycline for acute stroke treatment: a systematic review and meta-analysis of randomized clinical trials","volume":"265","author":"Malhotra","year":"2018","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jconrel.2021.10.020_bb0410","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00424-014-1454-x","article-title":"T-type calcium channel blockers as neuroprotective agents","volume":"466","author":"Kopecky","year":"2014","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0415","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0074-7742(08)60717-5","article-title":"Calcium antagonists: their role in neuroprotection","volume":"40","author":"Jacqueline Hunter","year":"1996","journal-title":"Int. Rev. Neurobiol."},{"issue":"4","key":"10.1016\/j.jconrel.2021.10.020_bb0420","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1472-8206.2010.00879.x","article-title":"Two structurally different T-type Ca 2+ channel inhibitors, mibefradil and pimozide, protect CA1 neurons from delayed death after global ischemia in rats","volume":"25","author":"Bancila","year":"2011","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0425","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/jpet.110.171058","article-title":"In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice","volume":"335","author":"Kraus","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0430","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/sj.jcbfm.9600532","article-title":"Propofol exerts greater neuroprotection with disodium edetate than without it","volume":"28","author":"Kotani","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"9","key":"10.1016\/j.jconrel.2021.10.020_bb0435","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.4103\/1673-5374.215240","article-title":"Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor","volume":"12","author":"Hern\u00e1ndez","year":"2017","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0440","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.redox.2017.09.010","article-title":"Neuroprotective effect of a new variant of Epo nonhematopoietic against oxidative stress","volume":"14","author":"Castillo","year":"2018","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2021.10.020_bb0445","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/jnr.21832","article-title":"Neuroprotective effects of erythropoietin posttreatment against kainate-induced excitotoxicity in mixed spinal cultures","volume":"87","author":"Yoo","year":"2009","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2021.10.020_bb0450","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/neu.2009.1001","article-title":"Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor","volume":"27","author":"Xiong","year":"2010","journal-title":"J. Neurotrauma"},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0455","first-page":"105","article-title":"Erythropoietin as a novel neuroprotectant","volume":"22","author":"Genc","year":"2004","journal-title":"Restor. Neurol. Neurosci."},{"issue":"5","key":"10.1016\/j.jconrel.2021.10.020_bb0460","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/neu.1999.16.347","article-title":"Neuroprotective effects of basic fibroblast growth factor following spinal cord contusion injury in the rat","volume":"16","author":"Lee","year":"1999","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0465","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2741\/2095","article-title":"Neuroprotective effect of granulocyte-colony stimulating factor","volume":"12","author":"Solaroglu","year":"2007","journal-title":"Front. Biosci."},{"issue":"1","key":"10.1016\/j.jconrel.2021.10.020_bb0470","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1574889811308010002","article-title":"The role of stem cell factor and granulocyte-colony stimulating factor in treatment of stroke","volume":"8","author":"Zhao","year":"2013","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0475","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.expneurol.2014.08.026","article-title":"NF-\u03baB is involved in brain repair by stem cell factor and granulocyte-colony stimulating factor in chronic stroke","volume":"263","author":"Cui","year":"2015","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.jconrel.2021.10.020_bb0480","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1471-4159.2006.03727.x","article-title":"Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson\u2019s disease","volume":"97","author":"Meuer","year":"2006","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.jconrel.2021.10.020_bb0485","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(97)00353-4","article-title":"Neuroprotective effects of the GABAA receptor partial agonist U-101017 in 3-acetylpyridine-treated rats","volume":"228","author":"Sethy","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0490","doi-asserted-by":"crossref","first-page":"35659","DOI":"10.1038\/srep35659","article-title":"Oxytocin modulates GABAAR subunits to confer neuroprotection in stroke in vitro","volume":"6","author":"Kaneko","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0495","article-title":"Gamma aminobutyric acid (GABA) receptor agonists for acute stroke","volume":"10","author":"Liu","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0500","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejphar.2016.04.036","article-title":"Involvement of AMPA\/kainate and GABAA receptors in topiramate neuroprotective effects against methylphenidate abuse sequels involving oxidative stress and inflammation in rat isolated hippocampus","volume":"784","author":"Motaghinejad","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.jconrel.2021.10.020_bb0505","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00702-017-1771-2","article-title":"Topiramate via NMDA, AMPA\/kainate, GABAA and Alpha2 receptors and by modulation of CREB\/BDNF and Akt\/GSK3 signaling pathway exerts neuroprotective effects against methylphenidate-induced neurotoxicity in rats","volume":"124","author":"Motaghinejad","year":"2017","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0510","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.lfs.2017.01.002","article-title":"Mediatory role of NMDA, AMPA\/kainate, GABAA and Alpha2 receptors in topiramate neuroprotective effects against methylphenidate induced neurotoxicity in rat","volume":"179","author":"Motaghinejad","year":"2017","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2021.10.020_bb0515","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ajh\/hpu197","article-title":"Neuroprotective effects of angiotensin receptor blockers","volume":"28","author":"Villapol","year":"2015","journal-title":"Am. J. Hypertens."},{"issue":"Pt 11","key":"10.1016\/j.jconrel.2021.10.020_bb0520","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1093\/brain\/awv172","article-title":"Neurorestoration after traumatic brain injury through angiotensin II receptor blockage","volume":"138","author":"Villapol","year":"2015","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.jconrel.2021.10.020_bb0525","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1042\/CS20120078","article-title":"AT(1) receptor blockers as treatments for inflammatory brain disorders","volume":"123","author":"Saavedra","year":"2012","journal-title":"Clin. Sci. (Lond.)"},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0530","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10571-015-0327-y","article-title":"Evidence to consider angiotensin II receptor blockers for the treatment of early Alzheimer\u2019s disease","volume":"36","author":"Saavedra","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2021.10.020_bb0535","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000200450","article-title":"Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome","volume":"27","author":"Fuentes","year":"2009","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0540","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000107384","article-title":"Action on vascular risk factors: importance of blood pressure and lipid lowering in stroke secondary prevention","volume":"24 Suppl. 1","author":"Fuentes","year":"2007","journal-title":"Cerebrovasc. Dis."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2021.10.020_bb0545","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2004.01.015","article-title":"Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events","volume":"221","author":"Greisenegger","year":"2004","journal-title":"J. Neurol. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2021.10.020_bb0550","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1212\/01.wnl.0000269789.09277.47","article-title":"Statin treatment withdrawal in ischemic stroke: a controlled randomized study","volume":"69","author":"Blanco","year":"2007","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.jconrel.2021.10.020_bb0555","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.JCN.0000305061.88624.fc","article-title":"High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review","volume":"23","author":"Schwertz","year":"2008","journal-title":"J. Cardiovasc. Nurs."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2017.09.019","article-title":"Antidiabetic drugs and stroke risk. Current evidence","volume":"48","author":"Castilla-Guerra","year":"2018","journal-title":"Eur J. Intern. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2021.10.020_bb0565","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.diabet.2017.04.004","article-title":"Impact of glucose-lowering therapies on risk of stroke in type 2 diabetes","volume":"43","author":"Bonnet","year":"2017","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0570","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijbiomac.2020.12.157","article-title":"Bio-functional hydrogel membranes loaded with chitosan nanoparticles for accelerated wound healing","volume":"170","author":"Shafique","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0575","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2147\/DDDT.S232111","article-title":"Engineering of naproxen loaded polymer hybrid enteric microspheres for modified release tablets: development, characterization, in silico modelling and in vivo evaluation","volume":"14","author":"Hameed","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0580","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.colsurfb.2016.08.027","article-title":"Drug nanocarrier, the future of atopic diseases: advanced drug delivery systems and smart management of disease","volume":"147","author":"Shao","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"4","key":"10.1016\/j.jconrel.2021.10.020_bb0585","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3390\/cancers13040670","article-title":"Recent advancements in stimuli responsive drug delivery platforms for active and passive cancer targeting","volume":"13","author":"Rahim","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0590","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.carbpol.2018.06.023","article-title":"Hyaluronic acid decorated tacrolimus-loaded nanoparticles: efficient approach to maximize dermal targeting and anti-dermatitis efficacy","volume":"197","author":"Zhuo","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0595","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.ijbiomac.2018.05.116","article-title":"Design and development of novel hyaluronate-modified nanoparticles for combo-delivery of curcumin and alendronate: fabrication, characterization, and cellular and molecular evidences of enhanced bone regeneration","volume":"116","author":"Dong","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0600","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijbiomac.2019.02.031","article-title":"Chitosan based thermosensitive injectable hydrogels for controlled delivery of loxoprofen: development, characterization and in-vivo evaluation","volume":"129","author":"Ahmad","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0605","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s40199-019-00308-w","article-title":"Recent advances in the delivery of disulfiram: a critical analysis of promising approaches to improve its pharmacokinetic profile and anticancer efficacy","volume":"27","author":"Farooq","year":"2019","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0610","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1208\/s12249-015-0287-z","article-title":"Targeting therapeutics across the blood brain barrier (BBB), prerequisite towards thrombolytic therapy for cerebrovascular disorders\u2014an overview and advancements","volume":"16","author":"Pulicherla","year":"2015","journal-title":"AAPS Pharm. Sci. Tech."},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0615","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s13346-018-0505-9","article-title":"Polymer-wrapped single-walled carbon nanotubes: a transformation toward better applications in healthcare","volume":"9","author":"Chik","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2021.10.020_bb0620","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4155\/tde-2016-0075","article-title":"Thermoresponsive curcumin\/DsiRNA nanoparticle gels for the treatment of diabetic wounds: synthesis and drug release","volume":"8","author":"Katas","year":"2017","journal-title":"Ther. Deliv."},{"issue":"7","key":"10.1016\/j.jconrel.2021.10.020_bb0625","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2174\/1567201814666170224142446","article-title":"Efficient colonic delivery of DsiRNA by pectin-coated polyelectrolyte complex nanoparticles: preparation, characterization and improved gastric survivability","volume":"14","author":"Hussain","year":"2017","journal-title":"Curr. Drug Deliv."},{"issue":"8","key":"10.1016\/j.jconrel.2021.10.020_bb0630","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2174\/1389450117666161125174625","article-title":"New insight in improving therapeutic efficacy of antipsychotic agents: an overview of improved in vitro and in vivo performance, efficacy upgradation and future prospects","volume":"19","author":"Ei Thu","year":"2018","journal-title":"Curr. Drug Targets"},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0635","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/03639045.2020.1716378","article-title":"HEMA based pH-sensitive semi IPN microgels for oral delivery; a rationale approach for ketoprofen","volume":"46","author":"Zia","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0640","article-title":"Fabrication, characterization and in vitro release kinetics of tofacitinib-encapsulated polymeric nanoparticles: a promising implication in the treatment of rheumatoid arthritis","author":"Bashir","year":"2020","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"issue":"1","key":"10.1016\/j.jconrel.2021.10.020_bb0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00914037.2019.1683558","article-title":"Nanotechnology guided newer intervention for treatment of osteoporosis: efficient bone regeneration by up-regulation of proliferation, differentiation and mineralization of osteoblasts","volume":"70","author":"Hussain","year":"2021","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0650","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1096\/fj.08-116947","article-title":"Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury","volume":"23","author":"Reddy","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0655","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.biomaterials.2015.12.009","article-title":"Tissue plasminogen activator followed by antioxidant-loaded nanoparticle delivery promotes activation\/mobilization of progenitor cells in infarcted rat brain","volume":"81","author":"Petro","year":"2016","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0660","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3233\/JAD-2012-112141","article-title":"Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line","volume":"30","author":"Doggui","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0665","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1021\/acs.molpharmaceut.5b00611","article-title":"Neuronal uptake and neuroprotective properties of curcumin-loaded nanoparticles on SK-N-SH cell line: role of poly(lactide-co-glycolide) polymeric matrix composition","volume":"13","author":"Djiokeng Paka","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0670","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.colsurfb.2016.11.036","article-title":"Nanoencapsulation, an efficient and promising approach to maximize wound healing efficacy of curcumin: a review of new trends and state-of-the-art","volume":"150","author":"Hussain","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0675","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.msec.2017.03.226","article-title":"Exploring recent developments to improve antioxidant, anti-inflammatory and antimicrobial efficacy of curcumin: a review of new trends and future perspectives","volume":"77","author":"Hussain","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"7","key":"10.1016\/j.jconrel.2021.10.020_bb0680","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.3109\/10717544.2014.941076","article-title":"PNIPAM nanoparticles for targeted and enhanced nose-to-brain delivery of curcuminoids: UPLC\/ESI-Q-ToF-MS\/MS-based pharmacokinetics and pharmacodynamic evaluation in cerebral ischemia model","volume":"23","author":"Ahmad","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0685","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.exger.2017.03.009","article-title":"Protective roles of nanomelatonin in cerebral ischemia-reperfusion of aged brain: matrixmetalloproteinases as regulators","volume":"92","author":"Sarkar","year":"2017","journal-title":"Exp. Gerontol."},{"issue":"10","key":"10.1016\/j.jconrel.2021.10.020_bb0690","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1055\/a-0596-7288","article-title":"Quantification and brain targeting of eugenol-loaded surface modified nanoparticles through intranasal route in the treatment of cerebral ischemia","volume":"68","author":"Ahmad","year":"2018","journal-title":"Drug Res."},{"issue":"28","key":"10.1016\/j.jconrel.2021.10.020_bb0695","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1016\/j.biomaterials.2013.05.021","article-title":"The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia","volume":"34","author":"Liu","year":"2013","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2021.10.020_bb0700","first-page":"2012","article-title":"Neuroprotective effect of tanshinone IIA weakens spastic cerebral palsy through inflammation, p38MAPK and VEGF in neonatal rats","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.jconrel.2021.10.020_bb0705","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1248\/bpb.b12-00769","article-title":"The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia\/reperfusion injury","volume":"36","author":"Zhao","year":"2013","journal-title":"Biol. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0710","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/jacs.6b11013","article-title":"Comprehensive insights into the multi-antioxidative mechanisms of melanin nanoparticles and their application to protect brain from injury in ischemic stroke","volume":"139","author":"Liu","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"10.1016\/j.jconrel.2021.10.020_bb0715","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1161\/STROKEAHA.116.016356","article-title":"Neurovascular unit protection from cerebral ischemia-reperfusion injury by radical-containing nanoparticles in mice","volume":"48","author":"Hosoo","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0720","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.2147\/IJN.S130842","article-title":"PEG-b-(PELG-g-PLL) nanoparticles as TNF-\u03b1 nanocarriers: potential cerebral ischemia\/reperfusion injury therapeutic applications","volume":"12","author":"Xu","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"27","key":"10.1016\/j.jconrel.2021.10.020_bb0725","doi-asserted-by":"crossref","first-page":"17897","DOI":"10.1074\/jbc.R900012200","article-title":"The RNA-induced silencing complex: a versatile gene-silencing machine","volume":"284","author":"Pratt","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0730","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biomaterials.2018.01.039","article-title":"Protecting neurons from cerebral ischemia\/reperfusion injury via nanoparticle-mediated delivery of an siRNA to inhibit microglial neurotoxicity","volume":"161","author":"Wang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0735","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.biomaterials.2017.11.047","article-title":"Thrombolytic therapy based on fucoidan-functionalized polymer nanoparticles targeting P-selectin","volume":"156","author":"Juenet","year":"2018","journal-title":"Biomaterials"},{"issue":"6095","key":"10.1016\/j.jconrel.2021.10.020_bb0740","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1126\/science.1227097","article-title":"Medicine. Leveraging shear stress to bust clots with nanoparticles","volume":"337","author":"Lavik","year":"2012","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.jconrel.2021.10.020_bb0745","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1161\/STROKEAHA.115.011063","article-title":"Shear-activated nanoparticle aggregates combined with temporary endovascular bypass to treat large vessel occlusion","volume":"46","author":"Marosfoi","year":"2015","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jconrel.2021.10.020_bb0750","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2217\/nnm.11.21","article-title":"A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke","volume":"6","author":"Marsh","year":"2011","journal-title":"Nanomedicine"},{"issue":"4","key":"10.1016\/j.jconrel.2021.10.020_bb0755","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2217\/17435889.2.4.533","article-title":"Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis","volume":"2","author":"Marsh","year":"2007","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0760","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/03639045.2012.668912","article-title":"Influence of lipid composition on the phase transition temperature of liposomes composed of both DPPC and HSPC","volume":"39","author":"Chen","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0765","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0770","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.jconrel.2021.10.020_bb0775","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/nano6070125","article-title":"Soft interaction in liposome nanocarriers for therapeutic drug delivery","volume":"6","author":"Lombardo","year":"2016","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0780","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejpb.2015.11.017","article-title":"Dual drug loaded nano-liposomal chemotherapy: a promising strategy for treatment of head and neck squamous cell carcinoma","volume":"99","author":"Mohan","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0785","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/fcp.12244","article-title":"Nanoliposome containing cyclosporine A reduced neuroinflammation responses and improved neurological activities in cerebral ischemia\/reperfusion in rat","volume":"31","author":"Partoazar","year":"2017","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.jconrel.2021.10.020_bb0790","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3390\/molecules23071747","article-title":"Preparation, characterization, pharmacokinetics and biodistribution of baicalin-loaded liposome on cerebral ischemia-reperfusion after i.v. administration in rats","volume":"23","author":"Li","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0795","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.brainres.2005.07.067","article-title":"CDP-choline liposomes provide significant reduction in infarction over free CDP-choline in stroke","volume":"1058","author":"Adibhatla","year":"2005","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0800","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jnr.10403","article-title":"Citicoline mechanisms and clinical efficacy in cerebral ischemia","volume":"70","author":"Adibhatla","year":"2002","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2021.10.020_bb0805","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.0022-3042.2001.00697.x","article-title":"Citicoline: neuroprotective mechanisms in cerebral ischemia","volume":"80","author":"Adibhatla","year":"2002","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.jconrel.2021.10.020_bb0810","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/jnr.10672","article-title":"Citicoline decreases phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia","volume":"73","author":"Adibhatla","year":"2003","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2021.10.020_bb0815","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1046\/j.1471-4159.2000.0752528.x","article-title":"Lipid alterations in transient forebrain ischemia: possible new mechanisms of CDP-choline neuroprotection","volume":"75","author":"Rao","year":"2000","journal-title":"J. Neurochem."},{"issue":"6301","key":"10.1016\/j.jconrel.2021.10.020_bb0820","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0825","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0830","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399411001918","article-title":"Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases","volume":"13","author":"Grammas","year":"2011","journal-title":"Expert Rev. Mol. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2021.10.020_bb0835","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","article-title":"Role of neuroinflammation in neurodegenerative diseases (review)","volume":"13","author":"Chen","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2021.10.020_bb0840","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.expneurol.2010.04.006","article-title":"Statins: multiple neuroprotective mechanisms in neurodegenerative diseases","volume":"230","author":"Wang","year":"2011","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.jconrel.2021.10.020_bb0845","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2011-110524","article-title":"Statins: the role in the treatment and prevention of Alzheimer\u2019s neurodegeneration","volume":"27","author":"Pac-Soo","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2021.10.020_bb0850","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pneurobio.2009.02.002","article-title":"Statins: mechanisms of neuroprotection","volume":"88","author":"van der Most","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0855","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.2147\/IJN.S107292","article-title":"Charge effect of a liposomal delivery systemencapsulating simvastatin to treat experimental ischemic stroke in rats","volume":"11","author":"Campos-Martorell","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0860","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1081\/LPR-64971","article-title":"Liposome opsonization","volume":"4215","author":"Yan","year":"2005","journal-title":"J. Liposome Res."},{"issue":"3","key":"10.1016\/j.jconrel.2021.10.020_bb0865","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13346-019-00631-4","article-title":"PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution","volume":"9","author":"Hussain","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0870","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.colsurfb.2017.11.008","article-title":"Magnesium lithospermate B loaded PEGylated solid lipid nanoparticles for improved oral bioavailability","volume":"161","author":"Kang","year":"2018","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0875","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2015.09.020","article-title":"Treatment of stroke with liposomal neuroprotective agents under cerebral ischemia conditions","volume":"97","author":"Fukuta","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0880","first-page":"1","article-title":"Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0885","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2016.04.038","article-title":"Dual targeted nanocarrier for brain ischemic stroke treatment","volume":"233","author":"Zhao","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0890","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biomaterials.2013.09.093","article-title":"Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG lipid nanoparticles","volume":"35","author":"Lu","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0895","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/jcbfm.2012.209","article-title":"Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury","volume":"33","author":"Yun","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0900","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jmmm.2016.10.122","article-title":"Preparation of thermosensitive magnetic liposome encapsulated recombinant tissue plasminogen activator for targeted thrombolysis","volume":"427","author":"Hsu","year":"2017","journal-title":"J. Magn. Magn. Mater."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0905","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1096\/fj.201601209R","article-title":"Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke","volume":"31","author":"Fukuta","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2455-7765.172998","article-title":"The optimal time window for the use and dosage of nimodipine for acute massive cerebral infarction: study protocol for a randomized controlled trial","volume":"1","author":"Li","year":"2016","journal-title":"Asia. Pac. J. Clin. Trials. Nerv. Syst."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0915","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/nano9060821","article-title":"Current applications of nanoemulsions in cancer therapeutics","volume":"9","author":"Sanchez-Lopez","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0920","series-title":"Applications of Nanotechnology in Drug Delivery","first-page":"193","article-title":"Nanoparticles for dermal and transdermal drug delivery","author":"Uchechi","year":"2014"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0925","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jconrel.2017.11.049","article-title":"Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications","volume":"270","author":"Rai","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0930","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","article-title":"Nanoemulsion: concepts, development and applications in drug delivery","volume":"252","author":"Singh","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0935","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.nano.2015.12.374","article-title":"Intranasal brain delivery of cationic nanoemulsion-encapsulated TNF\u03b1 siRNA in prevention of experimental neuroinflammation","volume":"12","author":"Yadav","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0940","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s12035-019-01730-6","article-title":"Nasal administration of cationic nanoemulsions as CD73-siRNA delivery system for glioblastoma treatment: a new therapeutical approach","volume":"57","author":"Azambuja","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.jconrel.2021.10.020_bb0945","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/10837450.2019.1705485","article-title":"Development and characterization of CD73-siRNA-loaded nanoemulsion: effect on C6 glioma cells and primary astrocytes","volume":"25","author":"Teixeira","year":"2020","journal-title":"Pharm. Dev. Technol."},{"issue":"6","key":"10.1016\/j.jconrel.2021.10.020_bb0950","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00280-020-04077-1","article-title":"CD73 as a target to improve temozolomide chemotherapy effect in glioblastoma preclinical model","volume":"85","author":"Azambuja","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"5","key":"10.1016\/j.jconrel.2021.10.020_bb0955","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s13346-018-0552-2","article-title":"Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends","volume":"8","author":"Choudhury","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"issue":"sup2","key":"10.1016\/j.jconrel.2021.10.020_bb0960","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/21691401.2018.1478420","article-title":"Nanomedicines as emerging platform for simultaneous delivery of cancer therapeutics: new developments in overcoming drug resistance and optimizing anticancer efficacy","volume":"46","author":"Hussain","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.10.020_bb0965","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/STROKEAHA.109.573477","article-title":"Effects of 0.6 mg\/kg intravenous alteplase on vascular and clinical outcomes in middle cerebral artery occlusion: Japan Alteplase clinical trial II (J-ACT II)","volume":"41","author":"Mori","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0970","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/ijs.12420","article-title":"Yamaguchi, Protocol for cilostazol stroke prevention study for antiplatelet combination (CSPS.com): a randomized, open-label, parallel-group trial","volume":"10","author":"Toyoda","year":"2015","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.jconrel.2021.10.020_bb0975","article-title":"Randomized, multicenter trial of argatroban with recombinant tissue plasminogen activator for acute stroke (ARTSS-2)","volume":"48","author":"Andrew","year":"2017","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb0980","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.STR.0000199064.94588.39","article-title":"Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator","volume":"37","author":"Molina","year":"2006","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jconrel.2021.10.020_bb0985","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/STROKEAHA.107.505727","article-title":"A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren\u2013lipid microspheres for acute ischemic stroke","volume":"39","author":"Alexandrov","year":"2008","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.jconrel.2021.10.020_bb0990","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.thromres.2012.06.020","article-title":"Effects of microbubbles on transcranial doppler ultrasound-assisted intracranial urokinase thrombolysis","volume":"130","author":"Liu","year":"2012","journal-title":"Thromb. Res."},{"issue":"10","key":"10.1016\/j.jconrel.2021.10.020_bb0995","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.ultrasmedbio.2008.02.011","article-title":"Do bubble characteristics affect recanalization in stroke patients treated with microbubble-enhanced sonothrombolysis?","volume":"34","author":"Rubiera","year":"2008","journal-title":"Ultrasound Med. Biol."},{"issue":"21","key":"10.1016\/j.jconrel.2021.10.020_bb1000","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201808361","article-title":"Microthrombus-targeting micelles for neurovascular remodeling and enhanced microcirculatory perfusion in acute ischemic stroke","volume":"31","author":"Lu","year":"2019","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2021.10.020_bb1005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1179\/1743132813Y.0000000259","article-title":"Edaravone, a free radical scavenger, attenuates cerebral infarction and hemorrhagic infarction in rats with hyperglycemia","volume":"36","author":"Okamura","year":"2014","journal-title":"Neurol Res"},{"issue":"2","key":"10.1016\/j.jconrel.2021.10.020_bb1010","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1517\/14656560802636888","article-title":"Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidative stress","volume":"10","author":"Higashi","year":"2009","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jconrel.2021.10.020_bb1015","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ejphar.2014.06.035","article-title":"The synergetic effect of edaravone and borneol in the rat model of ischemic stroke","volume":"740","author":"Wu","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.jconrel.2021.10.020_bb1020","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7150\/thno.18219","article-title":"Edaravone-encapsulated agonistic micelles rescue ischemic brain tissue by tuning blood-brain barrier permeability","volume":"7","author":"Jin","year":"2017","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.jconrel.2021.10.020_bb1025","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2174\/187152711796235023","article-title":"Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain","volume":"10","author":"Beg","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"12","key":"10.1016\/j.jconrel.2021.10.020_bb1030","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3390\/biom9120790","article-title":"Dendrimer-based drug delivery systems for brain targeting","volume":"9","author":"Zhu","year":"2019","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.jconrel.2021.10.020_bb1035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejpb.2008.09.023","article-title":"Dendrimers as versatile platform in drug delivery applications","volume":"71","author":"Svenson","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"10.1016\/j.jconrel.2021.10.020_bb1040","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2217\/17435889.3.5.679","article-title":"Dendrimers for enhanced drug solubilization","volume":"3","author":"Svenson","year":"2008","journal-title":"Nanomedicine"},{"issue":"5","key":"10.1016\/j.jconrel.2021.10.020_bb1045","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/1389557517666170512095151","article-title":"Dendrimers: general aspects, applications and structural exploitations as prodrug\/drug-delivery vehicles in current medicine","volume":"18","author":"Mariyam","year":"2018","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.jconrel.2021.10.020_bb1050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biomaterials.2015.07.006","article-title":"Salvaging brain ischemia by increasing neuroprotectant uptake via nanoagonist mediated blood brain barrier permeability enhancement","volume":"66","author":"Zheng","year":"2015","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.jconrel.2021.10.020_bb1055","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1177\/0271678X16656198","article-title":"Nanoagonist-mediated endothelial tight junction opening: a strategy for safely increasing brain drug delivery in mice","volume":"37","author":"Gao","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"4","key":"10.1016\/j.jconrel.2021.10.020_bb1060","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1021\/nn5003375","article-title":"Overcoming the blood-brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist","volume":"8","author":"Gao","year":"2014","journal-title":"ACS Nano"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921005496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921005496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:15:00Z","timestamp":1759162500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921005496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":212,"alternative-id":["S0168365921005496"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.10.020","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: A review","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}